International Journal of Cancer Management

Published by: Kowsar

Is Background Parenchymal Enhancement in Breast Magnetic Resonance Imaging Associated with Breast Cancer?

Afsaneh Alikhassi 1 , * , Sona Akbari Kia 1 , Seyedeh Nooshin Miratashi Yazdi 1 , Hedieh Akbari 1 and Farzin Roozafzai 1 , 2
Authors Information
1 Department of Radiology, Cancer Institute, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Digestive Disease Research Institute, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
Article information
  • International Journal of Cancer Management: May 2018, 11 (5); e64918
  • Published Online: May 12, 2018
  • Article Type: Research Article
  • Received: December 11, 2017
  • Revised: March 7, 2018
  • Accepted: March 10, 2018
  • DOI: 10.5812/ijcm.64918

To Cite: Alikhassi A, Akbari Kia S, Miratashi Yazdi S N, Akbari H, Roozafzai F. Is Background Parenchymal Enhancement in Breast Magnetic Resonance Imaging Associated with Breast Cancer?, Int J Cancer Manag. 2018 ; 11(5):e64918. doi: 10.5812/ijcm.64918.

Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Menezes GL, Knuttel FM, Stehouwer BL, Pijnappel RM, van den Bosch MA. Magnetic resonance imaging in breast cancer: A literature review and future perspectives. World J Clin Oncol. 2014;5(2):61-70. doi: 10.5306/wjco.v5.i2.61. [PubMed: 24829852]. [PubMed Central: PMC4014797].
  • 2. Bennani-Baiti B, Dietzel M, Baltzer PA. Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer. PLoS One. 2016;11(9). e0162936. doi: 10.1371/journal.pone.0162936. [PubMed: 27607428]. [PubMed Central: PMC5015914].
  • 3. Pike MC, Pearce CL. Mammographic density, MRI background parenchymal enhancement and breast cancer risk. Ann Oncol. 2013;24 Suppl 8:viii37-41. doi: 10.1093/annonc/mdt310. [PubMed: 24131968]. [PubMed Central: PMC3894109].
  • 4. King V, Brooks JD, Bernstein JL, Reiner AS, Pike MC, Morris EA. Background parenchymal enhancement at breast MR imaging and breast cancer risk. Radiology. 2011;260(1):50-60. doi: 10.1148/radiol.11102156. [PubMed: 21493794].
  • 5. van Gils CH, Hendriks JH, Holland R, Karssemeijer N, Otten JD, Straatman H, et al. Changes in mammographic breast density and concomitant changes in breast cancer risk. Eur J Cancer Prev. 1999;8(6):509-15. [PubMed: 10643940].
  • 6. Klifa C, Carballido-Gamio J, Wilmes L, Laprie A, Shepherd J, Gibbs J, et al. Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort. Magn Reson Imaging. 2010;28(1):8-15. doi: 10.1016/j.mri.2009.05.040. [PubMed: 19631485]. [PubMed Central: PMC4087111].
  • 7. Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G, Moschetta M. Breast MRI background parenchymal enhancement (BPE) correlates with the risk of breast cancer. Magn Reson Imaging. 2016;34(2):173-6. doi: 10.1016/j.mri.2015.10.014. [PubMed: 26597834].
  • 8. Dontchos BN, Rahbar H, Partridge SC, Korde LA, Lam DL, Scheel JR, et al. Are Qualitative Assessments of Background Parenchymal Enhancement, Amount of Fibroglandular Tissue on MR Images, and Mammographic Density Associated with Breast Cancer Risk? Radiology. 2015;276(2):371-80. doi: 10.1148/radiol.2015142304. [PubMed: 25965809]. [PubMed Central: PMC4554209].
  • 9. Morris EA. Diagnostic breast MR imaging: current status and future directions. Magn Reson Imaging Clin N Am. 2010;18(1):57-74. doi: 10.1016/j.mric.2009.09.005. [PubMed: 19962093].
  • 10. Muller-Schimpfle M, Ohmenhauser K, Stoll P, Dietz K, Claussen CD. Menstrual cycle and age: influence on parenchymal contrast medium enhancement in MR imaging of the breast. Radiology. 1997;203(1):145-9. doi: 10.1148/radiology.203.1.9122383. [PubMed: 9122383].
  • 11. Kawamura A, Satake H, Ishigaki S, Ikeda M, Kimura R, Shimamoto K, et al. Prediction of background parenchymal enhancement on breast MRI using mammography, ultrasonography, and diffusion-weighted imaging. Nagoya J Med Sci. 2015;77(3):425-37. [PubMed: 26412889]. [PubMed Central: PMC4574330].
  • 12. DeMartini WB, Liu F, Peacock S, Eby PR, Gutierrez RL, Lehman CD. Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR Am J Roentgenol. 2012;198(4):W373-80. doi: 10.2214/AJR.10.6272. [PubMed: 22451576].
  • 13. Boyd NF, Martin LJ, Sun L, Guo H, Chiarelli A, Hislop G, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2086-92. doi: 10.1158/1055-9965.EPI-06-0345. [PubMed: 17119032].
  • 14. Khazen M, Warren RM, Boggis CR, Bryant EC, Reed S, Warsi I, et al. A pilot study of compositional analysis of the breast and estimation of breast mammographic density using three-dimensional T1-weighted magnetic resonance imaging. Cancer Epidemiol Biomarkers Prev. 2008;17(9):2268-74. doi: 10.1158/1055-9965.EPI-07-2547. [PubMed: 18768492]. [PubMed Central: PMC2582975].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments